Prediction of the clinical risk of drug-induced cholestatic liver injury from in vitro rat sandwich cultured hepatocytes assay.
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: ITO, Kousei (Chiba University, Graduate School of Pharmaceuticak Sciences, Chiba, Japan)
- Co-author(s): Nozaki, Mayuka (Chiba University, Chiba, Japan)
Horie, Toshiharu (Teikyo Heisei University, Tokyo, Japan)
Sekine, Shuichi (Chiba University, Chiba, Japan)
[Background&Aim] It is important to assess the risk of drug induced liver injury (DILI) during the preclinical drug development process. We have established a rat sandwich cultured hepatocytes (rSCHs) based assay system to evaluate cholestatic DILI risk of each drug compound. However, it has not yet been confirmed if this in vitro assay system.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.